On Thursday, the Children’s Covid Vaccine Advisory Group (“CVAG”) wrote to the UK’s JCVI, Chris Whitty and Sajid Javid to urge an immediate pause to the Covid injection roll-out for children.

The request comes in light of new evidence of a potentially fatal safety signal in young males, which has not yet been investigated by regulators.  It cites findings from the US and Hong Kong showing a high prevalence of heart damage in boys and young men.

This is the second letter the JCVI has received in as many days urging for the child Covid injection roll-out to be paused.

On Wednesday, a separate group of 30 MPs, doctors and scientists, wrote: “We find it genuinely remarkable that, given the prior JCVI concerns, formal studies have not been put in place during the roll-out in these age groups with acknowledged limited benefit and significant knowledge gaps regarding safety … Pausing the current vaccine programme in children would allow time to undertake the necessary research which would resolve the difficulties affecting the current decision making.”

CVAG comprises more than 80 doctors, professors and scientists including leading professors in medicine, vaccine and risk, as well as paediatricians and general practitioners.

“We wrote to you and also the MHRA last month regarding urgent investigation of the acknowledged increase in all-cause mortality in males aged 15-19 since the Pfizer Covid vaccine roll-out commenced in this age group in May 2021,” CVAG’s letter began.

“ONS have acknowledged in the High Court in London, that the figure of 402 excess deaths is significantly higher than the previous 5-year average of 337* deaths. Indeed, they stated it is probably an underestimate because of delays for coroners’ cases.  This equates to at least one additional teenage boy dying each week.   It is thus very disappointing not to have received any response.”

[*Note: The 337 5-year average figure quoted in the letter has since been identified as incorrect. In fact, the 5-year average is 304 male deaths per year, indicating an excess of 96 deaths, equating to 2-3 excess deaths per week, as opposed to the 1 per week stated in the letter.  Also note that on account of anticipated delays in registration this figure could be around 4.5 excess deaths per week in boys in this age cohort. – Anna Brees Media]

“We are writing further to ask you to pause the vaccines for children while you undertake and publish an urgent review of the risk/benefit analysis.”

Regarding the, not so, benefits of vaccination CVAG noted:

• the official analysis failed to take due regard to naturally-acquired immunity, now demonstrated and widely accepted to be superior to vaccine acquired immunity;
• children have had high rates of infection throughout recent weeks with at least 80% now estimated to be immune; and
• the efficacy of Pfizer against omicron compared to previous variants is reduced to the point where infection rates are now higher in the vaccinated than the unvaccinated, creating an increased risk to contacts of the vaccinated.

Regarding the risks of vaccination CVAG noted:

• further information is available regarding myocarditis, with an occurrence rate of 1/2680 young men in Hong Kong, they paused their second dose, just as the UK moved from one to two doses;
• data from the US also confirms high myocarditis rates of 1/9443 in males aged 16-17 after their second dose;
• worrying information on all-cause mortality by vaccination status, which even from the original adult Pfizer trial showed a higher mortality for the vaccinated group;
• side effects are higher when vaccinating those already immune;
• non-fatal adverse events, particularly neurological, have the potential to blight the lives of affected children; and
• increasing evidence of impairment of immune function particularly following multiple doses of vaccine – Israel is now seeing serious illness and death after the fourth vaccine dose.

“The prospect now of widening the coverage to 5-11s would be all the more ludicrous. We should, like Norway & Sweden, make clear that vaccination for this age group is simply not necessary. 

“We would like to meet with you urgently, in order to support you in taking stock of all of the pertinent new and emerging data.”

You can read CVAG’s full letter, HERE.